Docosahexaenoic Acid but Not Eicosapentaenoic Acid Lowers Ambulatory Blood Pressure and Heart Rate in Humans
Authors:
- 1 August 1999
- journal article
- other
- Published by Wolters Kluwer Health in Hypertension
- Vol. 34 (2) , 253-260
Abstract
—Animal studies suggest that the 2 major ω3 fatty acids found in fish, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), may have differential effects on blood pressure (BP) and heart rate (HR). The aim of this study was to determine whether there were significant differences in the effects of purified EPA or DHA on ambulatory BP and HR in humans. In a double-blind, placebo-controlled trial of parallel design, 59 overweight, mildly hyperlipidemic men were randomized to 4 g/d of purified EPA, DHA, or olive oil (placebo) capsules and continued their usual diets for 6 weeks. Fifty-six subjects completed the study. Only DHA reduced 24-hour and daytime (awake) ambulatory BP ( P P =0.001). Relative to the placebo group, DHA reduced 24-hour HR by 3.5±0.8 bpm, daytime HR by 3.7±1.2 bpm, and nighttime HR by 2.8±1.2. EPA had no significant effect on ambulatory BP or HR. Supplementation with EPA increased plasma phospholipid EPA from 1.66±0.07% to 9.83±0.06% ( P P <0.0001) and led to a small, nonsignificant increase in EPA (1.52±0.12% to 2.26±0.16%). Purified DHA but not EPA reduced ambulatory BP and HR in mildly hyperlipidemic men. The results of this study suggest that DHA is the principal ω3 fatty acid in fish and fish oils that is responsible for their BP- and HR-lowering effects in humans. These results have important implications for human nutrition and the food industry.Keywords
This publication has 32 references indexed in Scilit:
- Dietary n-3 fatty acids in the prevention of lethal cardiac arrhythmiasCurrent Opinion in Lipidology, 1997
- The cardiovascular protective role of docosahexaenoic acidEuropean Journal of Pharmacology, 1996
- Protective effects of free polyunsaturated fatty acids on arrhythmias induced by lysophosphatidylcholine or palmitoylcarnitine in neonatal rat cardiac myocytesEuropean Journal of Pharmacology, 1996
- DIETARY DOCOSAHEXAENOIC ACID (22:6n‐3) PREVENTS THE DEVELOPMENT OF HYPERTENSION IN SHRSPClinical and Experimental Pharmacology and Physiology, 1995
- EFFECTS OF GAMMA‐LINOLENIC AND EICOSAPENTAENOIC ACIDS ON BLOOD PRESSURE IN SHRClinical and Experimental Pharmacology and Physiology, 1995
- Effects on blood pressure of omega 3 fats in subjects at increased risk of cardiovascular disease.Hypertension, 1993
- Marine oils dose-dependently inhibit vasoconstriction of forearm resistance vessels in humans.Hypertension, 1993
- FISH OIL FEEDING SELECTIVELY ATTENUATES CONTRACTILE RESPONSES TO NORADRENALINE AND ELECTRICAL STIMULATION IN THE PERFUSED MESENTERIC RESISTANCE VESSELS OF SPONTANEOUSLY HYPERTENSIVE RATSClinical and Experimental Pharmacology and Physiology, 1992
- Effect of Eicosapentaenoic and Docosahexaenoic Acids on Blood Pressure in HypertensionNew England Journal of Medicine, 1990
- The Antihypertensive Effects of Fish OilNew England Journal of Medicine, 1989